Bright Minds Biosciences Inc. (DRUG) vs Sight Sciences, Inc. (SGHT)
A side-by-side comparison of Bright Minds Biosciences Inc. and Sight Sciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DRUG
Bright Minds Biosciences Inc.
$48.23HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
SGHT
Sight Sciences, Inc.
$8.61HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — DRUG vs SGHT
growth of $100 · dividends reinvested · last 5yDRUG +121.3% (+17.2%/yr)SGHT -73.4% (-23.3%/yr)DRUG compounded faster over this window
Log scale — wide-divergence pair
DRUG SGHT
DRUG vs SGHT: by the numbers
- •DRUG is the larger company ($472M vs $469M market cap).
- •Both run net losses; DRUG's is the smaller (0.00% vs -35.69% net margin).
Metrics side by side
Valuation
| Metric | DRUG | SGHT |
|---|---|---|
| P/S ratio | N/A | 5.62 |
| P/B ratio | 2.17 | 8.86 |
Profitability
| Metric | DRUG | SGHT |
|---|---|---|
| Gross margin | 0.00% | 87.96% |
| Operating margin | 0.00% | -47.95% |
| Net margin | 0.00% | -35.69% |
| ROE | -8.21% | -56.26% |
| ROIC | -13.15% | -29.50% |
Growth (annualized)
| Metric | DRUG | SGHT |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 16.53% |
| Total return CAGR (5Y) | 6.76% | -18.69% |
Frequently asked
- How have DRUG and SGHT total returns compared?
- Over the past 5 years, DRUG delivered 6.76% and SGHT delivered -18.69% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bright Minds Biosciences ROESight Sciences ROEBright Minds Biosciences operating marginSight Sciences operating marginBright Minds Biosciences revenue growthSight Sciences revenue growthBright Minds Biosciences free cash flowSight Sciences free cash flow
Bright Minds Biosciences & Sight Sciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.